MedTech Showcase 2020
Gabe Musso, Chief Scientific Officer will be leading a presentation on how BioSymetrics is redefining AI-based Drug Discovery during the MedTech Showcase at #JPM2020. Topics will include how phenotype prediction can increase certainty of compound effects in vivo, identify off-target effects, reduce toxicity and shorten the path to market.